Cite

HARVARD Citation

    Rozeman, E. et al. (2020). Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM). Melanoma research. 30 (3), p. . [Online]. 
  
Back to record